Detailed Information on Publication Record
2016
Asymptomatic Elevation of Amylase and Lipase After Olanzapine Treatment
USTOHAL, Libor, Michaela MAYEROVÁ, Barbora VALKOVÁ, Hana SEDLÁKOVÁ, Tomáš KAŠPÁREK et. al.Basic information
Original name
Asymptomatic Elevation of Amylase and Lipase After Olanzapine Treatment
Authors
USTOHAL, Libor (203 Czech Republic, guarantor, belonging to the institution), Michaela MAYEROVÁ (203 Czech Republic, belonging to the institution), Barbora VALKOVÁ (203 Czech Republic, belonging to the institution), Hana SEDLÁKOVÁ (203 Czech Republic) and Tomáš KAŠPÁREK (203 Czech Republic, belonging to the institution)
Edition
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, PHILADELPHIA, LIPPINCOTT WILLIAMS & WILKINS, 2016, 0271-0749
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30104 Pharmacology and pharmacy
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 2.891
RIV identification code
RIV/00216224:14740/16:00090599
Organization unit
Central European Institute of Technology
UT WoS
000372100800018
Keywords in English
ACUTE-PANCREATITIS
Změněno: 30/8/2016 14:25, Mgr. Eva Špillingová
Abstract
V originále
Olanzapine, an atypical antipsychotic,has been considered one of the most efficient antipsychotic drugs, and it is the most frequently prescribed. It is categorized as a multiacting receptor targeted antipsychotic. The most significant adverse effects of olanzapine are metabolic: acute pancreatitis is one of the most serious adverse effects; fortunately, it does not occur very often. Koller et al1 found 51 cases,and at least 13 cases have been described more precisely. We present a case study of a young female patient with a very fast and high increase of amylase and lipase, who remained asymptomatic, immediately after olanzapine treatment.
Links
| LQ1601, research and development project |
|